Pfizer’s chief scientific officer and president of R&D, Mikael Dolsten, has said he will step down from the role in the coming months, kicking off the search for a successor. Dolsten’s ...

US pharmaceutical giant Pfizer on Tuesday said its chief scientific officer Mikael Dolsten, a key figure behind the development of the company's Covid-19 vaccine, would step down. Dolsten will be ...

According to the group’s soon-to-depart chief scientific officer, Mikael Dolsten, Pfizer has a “robust pipeline” of three clinical and several preclinical candidates. While danuglipron has ...

On Thursday, Starboard CEO Jeff Smith, accused Pfizer of skulduggery in forcing the pair to withdraw their support. He claimed that Read and D’Amelio had been contacted by company representatives, who ...

Mikael Dolsten – the chief scientific officer of Pfizer said in a press release today: Danuglipron has demonstrated good efficacy in a twice-daily formulation, and we believe a once-daily ...

Weeks before that, Pfizer announced that Dr. Mikael Dolsten, chief scientific officer and president of Pfizer research and development, would leave the company. The company also hired Andrew Baum, a ...

Nvidia has returned 700% during the Age of AI, but smaller companies may have more room to run. Pfizer, Tesla, and Kroger are ...

As Rocket Pharmaceuticals welcomes Dr. Mikael Dolsten from Pfizer to its Board of Directors, it's valuable to understand the financial health and market position of Pfizer (NYSE: PFE), where Dr ...

"Our ability to stop living in fear is now within reach," Mikael Dolsten, Pfizer's chief scientific officer, told Insider. "This should really break the fear, reduce the tremendous burden on ...

At the same time, Pfizer is searching outside the company for a new head of research and development before its longtime chief scientific officer Mikael Dolsten departs at the end of the year.

As Rocket Pharmaceuticals welcomes Dr. Mikael Dolsten from Pfizer to its Board of Directors, it's valuable to understand the financial health and market position of Pfizer (NYSE: PFE), where Dr.